- Home
- LXRX vs PFD Comparison
LXRX vs PFD Comparison
Compare LXRX & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- PFD
- Stock Information
- Founded
- LXRX 1995
- PFD 1990
- Country
- LXRX United States
- PFD United States
- Employees
- LXRX N/A
- PFD N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- LXRX Health Care
- PFD Finance
- Exchange
- LXRX Nasdaq
- PFD Nasdaq
- Market Cap
- LXRX 124.4M
- PFD 144.5M
- IPO Year
- LXRX 2000
- PFD N/A
- Fundamental
- Price
- LXRX $0.70
- PFD $11.08
- Analyst Decision
- LXRX Buy
- PFD
- Analyst Count
- LXRX 4
- PFD 0
- Target Price
- LXRX $3.67
- PFD N/A
- AVG Volume (30 Days)
- LXRX 5.7M
- PFD 33.2K
- Earning Date
- LXRX 05-13-2025
- PFD 01-01-0001
- Dividend Yield
- LXRX N/A
- PFD 6.30%
- EPS Growth
- LXRX N/A
- PFD N/A
- EPS
- LXRX N/A
- PFD N/A
- Revenue
- LXRX $31,081,000.00
- PFD N/A
- Revenue This Year
- LXRX N/A
- PFD N/A
- Revenue Next Year
- LXRX $84.78
- PFD N/A
- P/E Ratio
- LXRX N/A
- PFD N/A
- Revenue Growth
- LXRX 2481.48
- PFD N/A
- 52 Week Low
- LXRX $0.28
- PFD $8.53
- 52 Week High
- LXRX $2.45
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- LXRX 60.07
- PFD 58.60
- Support Level
- LXRX $0.63
- PFD $10.95
- Resistance Level
- LXRX $0.71
- PFD $11.10
- Average True Range (ATR)
- LXRX 0.07
- PFD 0.10
- MACD
- LXRX -0.00
- PFD 0.04
- Stochastic Oscillator
- LXRX 55.00
- PFD 88.54
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.